Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/BA310AFD.svg?ark=w1%2F20260515%2FBA310AFD)](https://nobleid.org/work/w1/20260515/BA310AFD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors